Ultrasound Guided Dextrose Prolotherapy: A Promising Hope for Temporomandibular Joint Dysfunction
Asian Journal of Dental Sciences,
Title of Topic: “Ultrasound guided dextrose prolotherapy: a promising hope for temporomandibular joint dysfunction”.
Background & Objectives: Temporomandibular joint disorder (TMD) is a term used to describe a group of medical disorders causing temporomandibular joint (TMJ) pain and dysfunction. Prolotherapy also known as regenerative injection therapy is effective in stabilizing injured TMJ and relieving joint pain by injecting a non-pharmacological irritant solution into the region of the tendons or ligaments. Traditionally prolotherapy will do blindly. Image guided prolotherapy improves the accuracy of injections through direct visualisation of the needle into the target. Thus the present study aimed to evaluate the advantages of ultrasound guided prolotherapy with 25% dextrose for the cases with TMDS.
Methods: The present study included 15 patients with temporomandibular joint dysfunction reported to the department of oral and maxillofacial surgery. All patients were treated with two sessions of injections with 3 ml of proliferant solution (2 ml of 25% dextrose and 2% lignocaine with 1:2,00,000 adrenaline) one month apart. Follow up was done for 1 month, 3 months and 6 months. The patients were evaluated for pain, frequency of dislocation or subluxation, clicking sound, deviation of mouth and for maximum mouth opening both pre and post-operatively and scores were recorded and analysed with wilcoxon matched pairs test and dependent t test.
Results: Our study showed significant improvement in TMJ pain, clicking sound, deviation of mouth, number of locking episodes and mouth opening after the two sessions of injections.
Interpretation and Conclusion: Ultrasound guided prolotherapy with 25% dextrose appears promising for the treatment of symptomatic TMJ dysfunction, as evidenced by therapeutic benefits, simplicity, safety, patients; acceptance of the injection technique and lack of significant side effects.
- Temporomandibular joint
- temporomandibular joint disorders
How to Cite
Moon S, Lee S, Ryu J. Ultrasound-guided platelet-rich plasma prolotherapy for temporomandibular disorders. J Oral Med Pain. 2014;39(4):140-145.
Hauser RA, Hauser MA, Blakemore KA. Dextrose prolotherapy and pain of chronic TMJ dysfunction: Practical Pain Management. 2007;11:49-55.
Ungor C, Atasoy KT, Taskesen F, Cezairli B, Dayisoylu EH, Tosun E, Senel FC. Short-term results of prolotherapy in the management of temporomandibular joint dislocation: J Craniofac Surg. 2013;24(2): 411-415.
Hakala RV, Ledermann KM.The use of prolotherapy for temporomandibular joint dysfunction. JProlotherapy. 2010;2(3):439-446.
Fouda AA. Change of site of intra-articular injection of hypertonic dextrose resulted in different effects of treatment. Br J Oral Maxillofac Surg. 2018;56:715–718.
Chen Y, Brundage C, Griffin SC, Murphy IC, De Luigi AJ. Ultrasound guided dextrose prolotherapy for persistent coccygeal pain: A case series and review of literature.AlternInteg Med. 2013;2(8):1-4.
Chakraborty A, Datta T, Lingegowda D, Khemka R. Ultrasound-guided temporomandibular joint injection for chronic post hemimandibulectomy jaw pain. AA Case Rep. 2016;7(10):203- 206.
Fullerton BD, Reeves D. Ultrasonography in regenerative injection (prolotherapy) using dextrose, platelet-rich plasma, and other injectants. Phys Med RehabilClin N Am.2010;21:585–605.
Banks AR. A rationale for prolotherapy. J Ortho Med. 1991;13(3):1-12.
Refai H, Altahhan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: A preliminary prospective, randomized, double-blind, placebo-controlled clinical trial: J Oral MaxillofacSurg.2011;69:2962-2970.
Reeves KD, Sit RWS, Rabago DP. Dextrose prolotherapy a narrative review of basic science, clinical research, and best treatment recommendations. Phys Med RehabilClin N Am. 2016;(27):783–823.
Ahn KH, Kim HS, Lee WK, et al. The effect of the prolotherapy on the injured Achilles tendon in a rat model. J Korean AcadRehabil Med. 2002;26:332–6.
Kim HJ, Jeong TS, Kim WS. Comparison of histological changes in accordance with the level of dextrose-concentration in experimental prolotherapy model. J Korean AcadRehabil Med.2003;27:935–40.
Oh S, EttemaAM, Zhao C, Zobitz ME, Wold LE, An K, Amadio PC. Dextrose-induced subsynovial connective tissue fibrosis in the rabbit carpal tunnel: A potential model to study carpal tunnel syndrome? Hand. 2008;3(1):34-40.
Refai H. Long-term therapeutic effects of dextrose prolotherapy inpatients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years’ follow up: Br J Oral Maxillofac Surg. 2017; 55:465–470
Majumdar SK, Krishna S, Chatterjee A, Chakraborty R, Ansari N. Single injection technique prolotherapy for hypermobility disorders of TMJ using 25% dextrose: Aclinical study. J Maxillofac Oral Surg. 2017; 16(2):226–230.
Zhou H, Hu K, Ding Y. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation: Br J Oral and Maxillofac Surg. 2014;52:63– 66.
Mustafa R, Gungormus M, Mollaoglu N. Evaluation of the efficacy of different concentrations of dextrose Prolotherapy in temporomandibular joint hypermobility treatment. J Craniofac Surg. 2018;29(5): 461-465.
Louw WF, Reeves KD, Lam SKH, Cheng A, Rabago D. Treatment of temporomandibular dysfunction with hypertonic dextrose injection (prolotherapy): A randomized controlled trial with long-term partial crossover. Mayo Clin Proc. 2019;94(5):1-13.
Cezairli B, Sivrikaya EC, Omezli MM, Ayranci F, Cezairli NS. Results of combined, single-session arthrocentesis and dextrose prolotherapy for symptomatic temporomandibular joint syndrome: A case series. J Altern Complement Med. 2017; 23(10):771-777.
Abstract View: 438 times
PDF Download: 423 times